Biotech Grants in Europe: EIC, Horizon and National Routes

Biotech grants in Europe depend heavily on stage, evidence and regulatory path. A discovery-stage research project, validation study and scale-up company will usually need different funding routes.

Quick answer: biotech startups should compare EIC Accelerator, Horizon Europe health-related calls, Eurostars, EIC Transition and national R&D schemes before committing to one application.

What biotech funders look for

Good fit signals

Biotech projects are stronger when they can show early evidence, a clear development path, defined users or patients, and a realistic plan for regulatory or clinical steps.

Red flags

Red flags include a vague mechanism of action, no validation plan, unrealistic timeline, weak IP position or a budget that does not connect to development milestones.

What to do next

Start with Cogrant: match biotech calls to your stage, evidence and regulatory path before drafting.

FAQ

Can biotech startups apply for EIC Accelerator?

Yes, if the project fits EIC innovation, risk, market and scale-up logic.

Does Horizon Europe fund biotech?

Yes, through relevant health, research and innovation topics, depending on the work programme.

Is Eurostars relevant for biotech?

It can be when an SME leads an international R&D project.

What should biotech teams prepare first?

Prepare scientific evidence, development plan, regulatory view, budget and team roles.